HOOKIPA Pharma
HOOK
HOOK was delisted on the 7th of August, 2025.
35 hedge funds and large institutions have $49.7M invested in HOOKIPA Pharma in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
75% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 8
13% more capital invested
Capital invested by funds: $44.1M → $49.7M (+$5.65M)
6% more funds holding
Funds holding: 33 → 35 (+2)
0.04% more ownership
Funds ownership: 3.03% → 3.07% (+0.04%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
+$4.85M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$380K |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
+$272K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$263K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$258K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$328K |
| 2 |
DIM
DC Investments Management
Mclean,
Virginia
|
-$288K |
| 3 |
Goldman Sachs
New York
|
-$254K |
| 4 |
Morgan Stanley
New York
|
-$99.8K |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
-$81.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SIC
26
Salem Investment Counselors
Winston Salem,
North Carolina
| $7K | – | – | – |
|
27
JP Morgan Chase
New York
| $5K | +$885 | +12 | +21% |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| $3K | -$41.4K | -561 | -93% |
|
29
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $3K | -$7.67K | -104 | -66% |
|
30
Wells Fargo
San Francisco,
California
| $2K | +$1.7K | +23 | +1,150% |
|
|
PCM
31
Prelude Capital Management
New York
| $2K | +$2.44K | +33 | New |
|
|
AIP
32
Ameritas Investment Partners
Lincoln,
Nebraska
| $1K | – | – | – |
|
33
Bank of Montreal
Toronto,
Ontario, Canada
| $1K | +$74 | +1 | +6% |
|
34
BNP Paribas Financial Markets
Paris,
France
| $780 | +$664 | +9 | +900% |
|
|
35
Millennium Management
New York
| – | -$328K | -4,875 | Closed |
|
|
DIM
36
DC Investments Management
Mclean,
Virginia
| – | -$288K | -4,286 | Closed |
|
|
37
Goldman Sachs
New York
| – | -$254K | -3,771 | Closed |
|
38
Citigroup
New York
| – | -$3.54K | -48 | -83% |
|
HOOK Hedge Fund Activity: Q3 2019 in Review
35 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q3 2019, worth a combined $49.7M — up 13% from $44.1M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new HOOK positions and 3 closed out — a net gain of 3 holders — while 14 added to existing stakes and 8 trimmed.
The largest buyer was HHLR Advisors, adding an estimated $4.85M. The largest seller was Millennium Management, exiting entirely with an estimated $328K sold.
- 35 institutional investors held HOOKIPA Pharma (HOOK) as of Q3 2019, up from 33 in Q2 2019.
- Funds reported $49.7M of HOOKIPA Pharma stock for Q3 2019, up 13% quarter-over-quarter.
- 6 funds opened new HOOKIPA Pharma positions in Q3 2019 and 3 closed out, a net change of +3 holders.
- The largest HOOKIPA Pharma buyer in Q3 2019 was HHLR Advisors, an estimated $4.85M added.
- The largest HOOKIPA Pharma seller in Q3 2019 was Millennium Management, an estimated $328K sold.
Based on aggregated 13F filings for Q3 2019.